India's Wockhardt rises as EU regulator clears drug for accelerated assessment
31/12/2025 07:44
** Shares of India's Wockhardt WCKH.NS rise 4.6% to 1438 rupees ** Drugmaker says European Medicines Agency clears co's medication targeting drug-resistant infections for accelerated assessment ** Stock up 1.8% YTD, set for slowest annual gains in three years (Reporting by Abhirami G in Bengaluru) ((abhirami.g@thomsonreuters.com))
Recent news on Wockhardt
See all newsBrief: Wockhardt Says Customs Authority Imposes 50 Million Rupees Penalty And 100 Million Rupees Redemption Fine On Co
Brief: Wockhardt Limited June-Quarter Consol Net Profit 1.06 Billion Rupees
India's Wockhardt gains after marketing authorization for antibiotic ZAYNICH
Brief: Wockhardt Says Indian Drug Regulator Grants Marketing Authorization To Co's Zaynich
India's Wockhardt hits 7‑month high after swinging to profit in fourth quarter